These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9761113)

  • 1. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) proteolysis in patients with colorectal cancer: possible association with the metastatic potential of the tumor.
    Baciuchka M; Remacle-Bonnet M; Garrouste F; Favre R; Sastre B; Pommier G
    Int J Cancer; 1998 Oct; 79(5):460-7. PubMed ID: 9761113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity.
    Bereket A; Lang CH; Blethen SL; Fan J; Frost RA; Wilson TA
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2282-8. PubMed ID: 7543110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I.
    Lee CY; Rechler MM
    Endocrinology; 1996 May; 137(5):2051-8. PubMed ID: 8612547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factors (IGFs) and IGF binding protein (IGFBP)-3 in patients with gastric cancer: IGFBP-3 protease activity induced by surgery.
    Lee DY; Yang DH; Kang CW; Kim SJ; Joo CU; Cho SC; Kim JS
    J Korean Med Sci; 1997 Feb; 12(1):32-9. PubMed ID: 9142657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex.
    Bang P; Brismar K; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 May; 78(5):1119-27. PubMed ID: 7513716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction.
    Salahifar H; Baxter RC; Martin JL
    Endocrinology; 1997 Apr; 138(4):1683-90. PubMed ID: 9075731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate carcinoma (PC-3) cell proliferation is stimulated by the 22-25-kDa proteolytic fragment (1-160) and inhibited by the 16-kDa fragment (1-95) of recombinant human insulin-like growth factor binding protein-3.
    Angelloz-Nicoud P; Lalou C; Binoux M
    Growth Horm IGF Res; 1998 Feb; 8(1):71-5. PubMed ID: 10990447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on human pregnancy-induced insulin-like growth factor (IGF)-binding protein-4 proteases in serum: determination of IGF-II dependency and localization of cleavage site.
    Byun D; Mohan S; Kim C; Suh K; Yoo M; Lee H; Baylink DJ; Qin X
    J Clin Endocrinol Metab; 2000 Jan; 85(1):373-81. PubMed ID: 10634413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay.
    Lassarre C; Binoux M
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1260-6. PubMed ID: 11238518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
    Miell JP; Langford KS; Jones JS; Noble P; Westwood M; White A; Nicolaides KH
    J Clin Endocrinol Metab; 1997 Jan; 82(1):287-92. PubMed ID: 8989275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum.
    Cianfarani S; Bonfanti R; Bitti ML; Germani D; Boemi S; Chiumello G; Boscherini B
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4162-7. PubMed ID: 11095448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolysis.
    Skjaerbaek C; Frystyk J; Orskov H; Kissmeyer-Nielsen P; Jensen MB; Laurberg S; Møller N; Flyvbjerg A
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2445-9. PubMed ID: 9661626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein (IGFBP)-3-bound IGF-I and IGFBP-3-bound IGF-II in growth hormone deficiency.
    Belgorosky A; Rivarola MA
    Horm Res; 1999; 52(2):60-5. PubMed ID: 10681634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
    Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
    Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases.
    Kanzaki S; Hilliker S; Baylink DJ; Mohan S
    Endocrinology; 1994 Jan; 134(1):383-92. PubMed ID: 7506211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
    Lalou C; Silve C; Rosato R; Segovia B; Binoux M
    Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor (IGF)-binding protein-4 proteolytic degradation in bovine, equine, and porcine preovulatory follicles: regulation by IGFs and heparin-binding domain-containing peptides.
    Mazerbourg S; Zapf J; Bar RS; Brigstock DR; Monget P
    Biol Reprod; 2000 Aug; 63(2):390-400. PubMed ID: 10906042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer.
    el Atiq F; Garrouste F; Remacle-Bonnet M; Sastre B; Pommier G
    Int J Cancer; 1994 May; 57(4):491-7. PubMed ID: 7514152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.